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Abstract 
Study design: Retrospective, observational, open label. 
Objective: We investigated the efficacy of facet debridement for the treatment of facet joint 
pain. 
Summary of background data: Facet joint disease, often due to degenerative arthritis, is 
common cause of chronic back pain. In patients that don’t respond to conservative measures, 
nerve ablation may provide significant improvement. Due to the ability of peripheral nerves to 
regenerate, ablative techniques of the dorsal nerve roots often provide only temporary relief. 
In theory, ablation of the nerve end plates in the facet joint capsule should prevent reinner-
vation.  
Methods: All patients treated with endoscopic facet debridement at our clinic from 2003-2007 
with at least 3 years follow-up were included in the analysis. Primary outcome measure was 
percent change in facet-related pain as measured by Visual Analog Scale (VAS) score at final 
follow-up visit.  
Results: A total of 174 people (77 women, 97 men; mean age 64, range 22-89) were included. 
Location of facet pain was cervical in 45, thoracic in 15, and lumbar in 114 patients. At final 
follow-up, 77%, 73%, and 68% of patients with cervical, thoracic, or lumbar disease, respec-
tively, showed at least 50% improvement in pain. Mean operating time per joint was 17 mi-
nutes (range, 10-42). Mean blood loss was 40 ml (range, 10-100). Complications included 
suture failure in two patients, requiring reclosure of the incision. No infection or nerve 
damage beyond what was intended occurred.  
Conclusions: Our results demonstrate a comparable efficacy of endoscopic facet debridement 
compared to radiofrequency ablation of the dorsal nerve branch, with durable results. Large 
scale, randomized trials are warranted to further evaluate the relative efficacy of this surgical 
treatment in patients with facet joint disease. 
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INTRODUCTION 
Facet joint disease, often due to degenerative 
arthritis, is common cause of chronic back pain. 
Among low back pain patients, facet joint disease is 
present in an estimated 7 to 75% 6. In epidemiological 
surveys, 40-45% of patients had evidence of facet joint 
pain based on anesthetic nerve blocks 9 10. 
Conservative therapy for facet joint pain consists 
of rest, physical therapy, and short-term use of non-Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
121
steroidal anti-inflammatory drugs or oral steroids 18. 
Local steroid injections and trigger point injects may 
provide rapid relief that continues to improve over 
5-7 days, but lacks evidence in the form of well de-
signed clinical trials 6 18 14 16 4. With steroid injection, 
pain relief can last anywhere from 2 months to 2 
years, but a subset of patients will have no significant 
benefit 18.  
In patients with continued pain despite these 
measures, nerve ablation may provide significant re-
lief. Rhizotomy is commonly performed by radiofre-
quency ablation (RFA); cryo-denervation has been 
reported in Europe 2 17 1. Ablation of the dorsal nerve 
roots supplying the painful facet joint provides sig-
nificant relief, but due the innate ability of peripheral 
nerves to regenerate, improvement is impermanent. 
Theoretically, removal of the capsular tissue within 
the joint, which contains the peripheral nerve 
endplate receptors, should prevent nerve regenera-
tion. Without endplate receptors present within the 
joint, dorsal root axons should be incapable of 
re-innervating the joint. 
In this study we investigate the long-term effi-
cacy of facet debridement for the treatment of chronic 
back pain originating in the facet joint.  
MATERIALS AND METHODS 
Patient enrollment and evaluation 
All patients treated with endoscopic facet de-
bridement at our institution from 2003-2007 with at 
least 3 years follow-up were included in the analysis. 
Patients were diagnosed based on response to facet 
injections as follows: 1 ml of 0.25% bupivacaine was 
injected using a 22 gauge needle with fluoroscopic 
guidance into the joints near their reported pain. Pa-
tients with at least 75% improvement in their back 
pain immediately following injection were diagnosed 
with facet pain.   
Primary outcome measure was percent change 
in facet-related pain as measured by Visual Analog 
Scale (VAS) score at final follow-up visit. Secondary 
outcome was change in OSWESTRY disability index 
from preoperative evaluation to final follow-up. 
Surgical procedure 
The procedure commenced as follows: the pa-
tient is appropriately prepped and draped. Using 
fluoroscopic guidance, the facet joints are identified. 
An incision of between ½ to ¾ of an inch is made in 
the skin at the entry site. A guide wire is inserted 
down to the facet joint and then secured into the joint 
surface.  A dilation system is inserted over the guide 
wire and used to dilate the tissues and to allow ade-
quate working environment. Various final dilation 
sizes were utilized during the study with a range of 7 
to 14mm. The various sizes were utilized to determine 
the minimal size needed to achieve the procedure. 
Through the final dilation portal, pituitaries are then 
used to remove the capsular tissue under direct ob-
servation via a standard laparoscopic scope system. 
The scope size varied based on the size of the portal 
and ranged from 2.7 to 7mm in diameter. Electrocau-
tery and holmium lasers are also used to complete the 
denuding of the joint surface to insure that the com-
plete capsular region was removed. Once the joint is 
completely denuded of capsular tissue, the dilation 
system is removed and the site closed with subcuta-
neous sutures. Each joint takes approximately 15 to 20 
minutes to properly treat. A maximum of 6 joints 
were treated at any time; most patients required 
treatment of 4 joints: 116 people had 4 joints treated 
(bilateral joints times two levels), 32 had 6 joints or 3 
levels bilateral, and 26 had one level bilateral or two 
joints treated. The reason the maximum treated joints 
was 6 is due to time restraints of the surgery.  
RESULTS 
A total of 174 people (77 women, 97 men; mean 
age 64, range 22-89) were included. Length of fol-
low-up was at least 3 years with a maximum of 6 
years. Location of facet pain was cervical in 45, tho-
racic in 15, and lumbar in 114 patients. 
Surgical times varied based on the number of 
joints treated. Mean operating time per joint was 17 
minutes (range, 10-42). Mean blood loss was 40 ml 
(range, 10-100). Complications included suture failure 
in two patients, requiring re-closure of the incision. 
No infection or nerve damage beyond what was in-
tended occurred.  
Table 1 reports percent change in VAS at fol-
low-up. A total of 77%, 73%, and 68% of patients with 
cervical, thoracic, or lumbar disease, respectively, 
showed at least 50% improvement in pain at last fol-
low-up. Table 2 reports change in Oswestry score 
from preoperative evaluation to final follow-up. 
Overall, 76%, 60%, and 75% of patients with cervical, 
thoracic, or lumbar facet disease, respectively, had at 
least 50% improvement.  
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Table 1.  Percent change in VAS pain score at long-term follow-up according to location of facet joint pain. 
% Change VAS  No Change (N) 1-24%  (N) 25-49%  (N)  50-74% (N)  75-100% (N) Total  (N) 
Cervical 5  3  2  2  33  45 
Thoracic 4  0  0  3  8  15 
Lumbar 11  11  15  15  62  114 
 
 
Table 2. Percent change in Oswestry Disability Index at long-term follow-up according to location of facet joint pain. 
% Change Oswestry -1-25%  No  Change (N) 1-24%  (N)  25-49% (N)  50-74% (N)  75-100% (N) Totals  (N) 
Cervical 1  3  2  5  8  26 45 
Thoracic 0  5  1  0  3  6 15 
Lumbar 1  8  7  13  17  68 114 
 
 
In comparison of the endoscopic surgery ap-
proach to conventional facet joint therapies, out of the 
114 lumbar facet patients, 72 patients underwent facet 
injections elsewhere as treatment prior to considering 
the endoscopic option. The facet injections in these 72 
patients gave 50 to 100% relief of their pain in 86% of 
the patients with a median relief period of 3 months. 
The range of relief varied from zero days to up to 13 
months for the facet injection group. None of the 
lumbar facet injection patients received permanent 
relief. Of the 114 lumbar facet patients, 26 underwent 
radiofrequency lesioning of the dorsal rami nerves 
prior to considering the endoscopic surgery option. Of 
these 26 patients, 14 patients had 50 to 100% relief 
with a median period of pain relief being 5 months. 
The range of relief for the radiofrequency group was 
from zero days to 16 months for all 26 patients who 
underwent the radiofrequency procedure. Of the 14 
patients who revealed 50% or greater improvement 
from the radiofrequency procedure, the length of im-
provement varied from 3 months to 16 months. 
Again, no one in the radiofrequency group developed 
permanent relief of their pain. Thus, the endoscopic 
facet procedure offered long-term relief beyond what 
was seen when the patients underwent facet injections 
or rhizotomy procedures.  
DISCUSSION 
Studies of radiofrequency ablation (RFA) for fa-
cet pain report rapid symptomatic relief. Success rates 
range from 21-71%. However, most studies are small 
in size, do not include a control group, and have li-
mited follow-up. Because of the capacity for peri-
pheral nerves to regenerate, long term outcome fol-
lowing ablation of the dorsal nerve root or its 
branches should be evaluated. Cho et al. 3 reported a 
71% success rate in 324 patients at a mean follow-up 
of 22.5 months. Tzaan et al. 19 reported good results at 
a mean follow-up of 5 months in 41% of 90 patients. 
Schaerer 13 reported good to excellent results in 50% of 
patients with cervical facet disease and 35% of pa-
tients with lumber disease after a mean follow-up of 
13.7 months. Iwatsuki et al. 5 reported significant pain 
relief in 71% of 21 patients at one year follow-up with 
laser denervation of the dorsal facet capsule. Li et al. 8 
treated 5 patients with RFA of the dorsal rami. Three 
patients had durable response after 6 to 16 months 
follow-up; two patients had no pain relief. Other au-
thors have reported similar success rates but with 
limited or no follow-up data 7 12 15 11. 
Cryorhizotomy is reported in to be of similar ef-
ficacy. In a study of 76 patients treated via CT-guided 
cryorhizotomy of the dorsal nerve medial branch, 
Staender et al. 17 reported a mean VAS pain score re-
duction of 3.3 at six months follow-up; 40% of patients 
had relief for at least 12 months, and mean duration of 
pain relief was 14 months. Barlocher et al. 1 treated 50 
patients with cryorhizotomy of the medial branch. At 
1-year follow up, 62% had good results.  
Our results are similar to those reported with 
RFA and cryorhizotomy. Importantly, the majority of 
our patients reported significant pain improvement 
for at least 36 months postoperatively. This durable 
effect is particularly promising, given the propensity 
for facet joint pain to return following dorsal root 
rhizotomy. We speculate that the direct visualization 
of the joint allows better de-innervation of the joint 
and removal of the entire end-plate receptors that 
adhere to the bone and capsular tissue.  
Limitations of the current study include a lack of 
comparison group and lack of blinding. A rando-
mized, controlled clinical trial would be ideal to fur-
ther verify the efficacy we report here. We chose to 
include only patients with long-term follow-up in 
order to provide data on the duration of pain relief. 
The exclusion of patients with less than 3 years fol-
low-up may bias our results, as patients with unsuc-
cessful results may have left our clinic and received 
therapy elsewhere.  
In conclusion, facet joint pain is a significant Int. J. Med. Sci. 2010, 7 
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source of chronic back pain and responds well to 
nerve ablation techniques. Our results demonstrate 
efficacy of endoscopic facet debridement comparable 
to the more commonly used RFA, with results durable 
for at least 3 years. Larger scale trials with a control 
group are warranted to further evaluate the relative 
efficacy of this surgical treatment in patients with 
facet joint disease.  
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